References
- Peravozchykava M. Efficacy of N-acetylcysteine on prevention and amelioration of cisplatin-induced ototoxicity: a systematic literature review. CUNY Academic Works. 2014;6:1–48.
- Chirtes F, Albu S. Prevention and restoration of hearing loss associated with the use of cisplatin. Biomed Res Int. 2014;2014:925485–925489.
- Freyer DR, Brock P, Knight K, et al. Interventions for cisplatin-induced hearing loss in children and adolescents with cancer. Lancet Child Adolesc Health. 2019;3(8):578–584.
- Visacri MB, Quintanilha JC, de Sousa VM, et al. Can acetylcysteine ameliorate cisplatin-induced toxicities and oxidative stress without decreasing antitumor efficacy? A randomized, double-blind, placebo-controlled trial involving patients with head and neck cancer. Cancer Med. 2019;8(5):2020–2030.
- Dickey DT, Wu YJ, Muldoon LL, et al. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels. J Pharmacol Exp Ther. 2005;314(3):1052–1058.
- Choe WT, Chinosornvatana N, Chang KW. Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate. Otol Neurotol. 2004;25(6):910–915.
- Wang Y, Han L, Diao T, et al. A comparison of systemic and local dexamethasone administration: from perilymph/cochlea concentration to cochlear distribution. Hear Res. 2018;370:1–10. 12():
- Ekborn A, Laurell G, Johnstrom P, et al. D-methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics. Hear Res. 2002;165(1-2):53–61.
- Ozturk M, Ucar S, Sarı F, et al. Possible protective effect of sertraline against cisplatin-induced ototoxicity: an experimental study. Sci World J. 2013;2013:1–5.,
- Malberg JE, Blendy JA. Antidepressant action: to the nucleus and beyond. Trends Pharmacol Sci. 2005;26(12):631–638.
- Feghali JG, Liu W, Van De Water TR. L-N-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope. 2001;111(7):1147–1155.
- Dickey DT, Muldoon LL, Kraemer DF, et al. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model . Hear Res. 2004;193(1-2):25–30.
- Lorito G, Hatzopoulos S, Laurell G, et al. Dose-dependent protection on cisplatin-induced ototoxicity- an electrophysiological study on the effect of three antioxidants in the sprague-dawley rat animal model. Med Sci Monitor. 2010;17(8):179–186.
- Nader ME, Theoret Y, Saliba I. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity. Laryngoscope. 2010;120(6):1208–1213.
- Saliba I, El Fata F, Ouelette V, et al. Are intratympanic injections of nacetylcysteine and methylprednisolone protective against cisplatin-induced ototoxicity? J Otolaryngol Head Neck Surg. 2010;39(3):236–243.
- Lin PC, Lee MY, Wang WS, et al. Has neuroprotective effects against oxaliplatinbased adjuvant chemotherapy in Colon cancer patients: preliminary data. Support Care Cancer. 2006;14(5):484–487.
- Yoo J, Hamilton SJ, Angel D, et al. Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients. Laryngoscope. 2013;124(3):87–94.
- Riga MG, Chelis L, Kakolyris S, et al. Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy. Am J Clin Oncol. 2013;36(1):1–6.
- Yıldırım M, Inançlı HM, Samancı B, et al. Preventing cisplatin induced ototoxicity by N-acetylcysteine and salicylate. Kulak Burun Bogaz Ihtis Derg. 2010;20(4):173–183.
- Abi-Hachem RN, Zine A, Van De Water TR. The injured cochlea as a target for inflammatory processes, initiation of cell death pathways and application of related otoprotectives strategies. Recent Pat CNS Drug Discov. 2010;5(2):147–163.